Department of Neurosurgery, Albany Medical Center, Albany, NY, USA.
Department of Neuroscience, Florida Atlantic University, Boca Raton, FL, USA.
Interv Neuroradiol. 2024 Apr;30(2):163-169. doi: 10.1177/15910199221104616. Epub 2022 Jun 1.
As we emerge from the current pandemic, hospitals, staff, and resources will need to continue to adjust to meet ongoing healthcare demands. Lessons learned during past shortages can be used to optimize peri-procedural protocols to safely improve the utilization of hospital resources.
Retrospective review of patients who underwent elective endovascular intracranial aneurysm treatment was performed. Multivariable logistic regression was used to identify factors associated with patients who were able to be discharged within 24 h of elective procedures. Rates of complications (particularly readmission) were determined.
330 patients underwent elective endovascular aneurysm treatment with 86 (26.1%) discharged within 24 h. Factors associated with earlier discharge included procedure years (2019-2021) and male sex Patients were more likely to be discharged later (after 24 h) if they underwent stent-coil embolization or flow-diversion. There was no association between discharge timing and likelihood of readmission.
Our review highlights the safety of earlier discharge and allowed us to prepare a fast-track protocol for same-day discharge in these patients. This protocol will be studied prospectively in the next phase of this study. As we gain more comfort with emerging, minimally invasive endovascular therapies, we hope to safely achieve same-day discharge on a protocolized and routine basis, reducing the demand of elective aneurysm treatments on our healthcare system.
We retrospectively demonstrate that early discharge following elective aneurysm treatment is safe in our cohort and provide a fast-track pathway based on these findings for other centers developing similar protocols.
随着我们走出当前的大流行,医院、员工和资源将需要继续调整以满足持续的医疗保健需求。过去短缺时期吸取的经验教训可用于优化围手术期协议,以安全地提高医院资源的利用效率。
对择期进行血管内颅内动脉瘤治疗的患者进行回顾性研究。采用多变量逻辑回归分析确定与能够在择期手术后 24 小时内出院的患者相关的因素。确定并发症(特别是再入院)的发生率。
330 例患者接受了择期血管内动脉瘤治疗,其中 86 例(26.1%)在 24 小时内出院。与更早出院相关的因素包括手术年份(2019-2021 年)和男性。如果患者接受支架线圈栓塞或血流转向治疗,他们更有可能较晚(24 小时后)出院。出院时间与再入院的可能性之间没有关联。
我们的回顾性研究强调了更早出院的安全性,并使我们能够为这些患者制定 24 小时内出院的快速通道方案。下一阶段的研究将对此方案进行前瞻性研究。随着我们对新兴的微创血管内治疗方法越来越有信心,我们希望能够安全地按协议和常规实现 24 小时内出院,从而减少我们的医疗保健系统对择期动脉瘤治疗的需求。
我们回顾性地证明了在我们的队列中,择期动脉瘤治疗后早期出院是安全的,并根据这些发现为其他正在制定类似方案的中心提供了快速通道途径。